Atomo Diagnostics Limited (AT1.AX)

0.0310 +0.0010 (+3.33%) At close: 04:10PM AEST

Atomo Diagnostics Limited

3-5 George Street
Level 1
Leichhardt, NSW 2040
Australia
61 2 9099 4750
https://atomodiagnostics.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. John Michael Kelly	Founder, CEO, MD & Director	527.16k	N/A	N/A
Ms. Chandra Sukumar	Chief Operating Officer	324.29k	N/A	N/A
Mr. Jim P. McMenamy	Head of Business Development & Partnerships of the Americas	N/A	N/A	N/A
Ms. Anna Tucker	Head of Business Development & Partnerships of Europe, Middle East and Africa	N/A	N/A	N/A
Ms. Maria Clemente	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for HIV screening, pregnancy test, and respiratory test. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Corporate governance

Atomo Diagnostics Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.